Eckert & Ziegler SE (LON: 0NZY)
London
· Delayed Price · Currency is GBP · Price in EUR
39.74
+0.01 (0.03%)
Jul 22, 2022, 8:03 AM BST
Eckert & Ziegler SE Revenue
Eckert & Ziegler SE had revenue of 70.11M EUR in the quarter ending September 30, 2024, with 6.39% growth. This brings the company's revenue in the last twelve months to 277.72M, up 15.56% year-over-year. In the year 2023, Eckert & Ziegler SE had annual revenue of 246.09M with 10.74% growth.
Revenue (ttm)
277.72M EUR
Revenue Growth
+15.56%
P/S Ratio
n/a
Revenue / Employee
258.35K EUR
Employees
1,075
Market Cap
855.35M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 246.09M | 23.86M | 10.74% |
Dec 31, 2022 | 222.23M | 41.79M | 23.16% |
Dec 31, 2021 | 180.44M | 4.30M | 2.44% |
Dec 31, 2020 | 176.14M | -2.35M | -1.32% |
Dec 31, 2019 | 178.49M | 9.78M | 5.80% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |